MedTrace Logo

Prevalence and Determinants of Chronic Obstructive Pulmonary Disease (COPD) in HIV+ Patients

NCT00904384 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 350

Last updated 2011-06-10

No results posted yet for this study

Summary

The prevalence of COPD in HIV+ and AIDS patients is unknown. The pathophysiology of HIV infection and COPD might be of interest to both conditions. The research hypotheses of this study are:

In patients with HIV infection living in the Autonomous Community of the Balearic Islands (CAIB):

1. The Prevalence of airflow obstruction in patients with HIV infection is higher than in the general population.
2. In these patients, the prevalence of emphysema detected by HRCT is common (greater than or equal to 15%)
3. DLCO measurement is a good marker for the presence of emphysema on CT
4. The inflammatory response is different from that seen in patients with COPD and / or emphysema without HIV infection

Conditions

  • HIV Infections
  • COPD

Sponsors & Collaborators

  • Hospital Universitari Son Dureta

    collaborator OTHER

  • Cimera

    lead NETWORK

Principal Investigators

  • Melchor Riera, MD · Hospital Universitario Son Dureta

Eligibility

Min Age
40 Years
Max Age
69 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-07-31
Primary Completion
2011-01-31
Completion
2011-01-31

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00904384 on ClinicalTrials.gov